Volume 10 Number 5/6 May/June 2009
8 June 2009. Related: Editorial.
2009
15th Annual Conference of the British HIV Association (BHIVA), 1-3 April 2009, Liverpool
8 June 2009. Related: Conference reports.
Superinfection identified in 2 out of 8 patients with unexpected viral load increases
8 June 2009. Related: Conference reports.
Peripheral DEXA scans to identify rates of reduced bone mineral density
8 June 2009. Related: Conference reports.
Vitamin D deficiency, supplementation and tenofovir
8 June 2009. Related: Conference reports.
High rate of lost and untested TB biopsy samples and low screening for latent TB
8 June 2009. Related: Conference reports, TB coinfection.
16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2009, Montreal
8 June 2009. Related: Conference reports.
Assessing the cardiovascular impact of HIV, abacavir, and new signals for lopinavir/r
3 June 2009. Related: Conference reports, Side effects.
Intensive smoking cessation programme reports limited success at 6 months
3 June 2009. Related: Conference reports, Side effects.
HDL particle concentration predicts cardiovascular disease in SMART
3 June 2009. Related: Conference reports, Side effects.
No effect of hormonal contraception on HIV disease progression in large multi-country cohort
3 June 2009. Related: Conference reports, Women's health.
Pregnancy, family planning, and HIV acquisition in HPTN 039
3 June 2009. Related: Conference reports, Pregnancy.
Progression and regression of pre-malignant cervical lesions in HIV-positive women from Soweto
3 June 2009. Related: Conference reports.
CD4 count >250 not predictive of rash-associated hepatoxicity among women initiating nevirapine-based ART in Zambia, Thailand, and Kenya
3 June 2009. Related: Conference reports, Side effects.
HIV testing of infants at immunisation clinics in Kwazulu-Natal
3 June 2009. Related: Conference reports.
Rapid HIV disease progression in South African infants co-infected with cytomegalovirus (CMV)
3 June 2009. Related: Conference reports, Coinfections and complications.
Pharmacokinetic studies in very young infants
3 June 2009. Related: Conference reports, Paediatric care.
Double-dose lopinavir/ritonavir provides insufficient lopinavir exposure in children receiving rifampicin
3 June 2009. Related: Conference reports, Paediatric care, TB coinfection.
PI-based ART in children with HIV and HIV/TB coinfection in South Africa
3 June 2009. Related: Conference reports, Paediatric care, TB coinfection.
Etravirine dose selection in children aged 6 to 17
3 June 2009. Related: Conference reports, Paediatric care.
Preliminary results from first paediatric raltegravir study
3 June 2009. Related: Conference reports.
10th International Workshop on Clinical Pharmacology of HIV Therapy, 15-17 April 2009, Amsterdam
3 June 2009. Related: Conference reports.
Efavirenz lowers levels of darunavir given as 900/100mg once daily with ritonavir
3 June 2009. Related: Conference reports, PK and drug interactions.
How much (or how little) ritonavir do you need to boost another PI?
3 June 2009. Related: Conference reports.
Genetic markers linked to early discontinuation of three antiretrovirals
3 June 2009. Related: Conference reports, Side effects.
4th South African AIDS Conference, 31 March-3 April 2009, Durban, South Africa
3 June 2009. Related: Conference reports.
HAART coverage and unmet need in South Africa
3 June 2009. Related: Conference reports.
EMEA positive opinion on using tipranavir and darunavir in younger patients
3 June 2009. Related: Antiretrovirals.
Lopinavir/r (Kaletra) cardiovascular risk requires FDA label changes
3 June 2009. Related: Antiretrovirals.
NEJM paper: NA-ACCORD cohort study on when to start treatment
3 June 2009. Related: Antiretrovirals.
NA ACCORD results support the importance of the START study: response to researchers
3 June 2009. Related: Antiretrovirals.
EMEA statement on abacavir and the risk of heart attack
3 June 2009. Related: Antiretrovirals.
Access to HIV treatment for UK prisoners
3 June 2009. Related: Treatment access, BHIVA news.
HIV and hepatitis coinfection guidelines (2009): online for comment
3 June 2009. Related: Guidelines, Hepatitis coinfection, BHIVA news.
Potential interactions between antiviral treatment for swine flu (H1N1) and anti-HIV therapy
2 June 2009. Related: PK and drug interactions.
Case reports of significant interactions between etravirine and raltegravir
2 June 2009. Related: PK and drug interactions.
US pregnancy guidelines updated (2009)
2 June 2009. Related: Guidelines.
Whole body CD4 T cell census questions role of gut
2 June 2009. Related: Basic science and immunology.
Gut bacteria breach the barrier: further confirmation of microbial translocation in HIV infection
2 June 2009. Related: Basic science and immunology.
Update on (another) Berlin patient
2 June 2009. Related: Cure-related research, Basic science and immunology.
Iowa: Gay man gets 25 years for one-time non-disclosure to a single complainant
2 June 2009. Related: Other news.
US denies entry to 60 HIV-positive Canadians
2 June 2009. Related: Other news.
Job vacancy: Editor post for of the Southern African Journal on HIV Medicine for the nursing profession
2 June 2009. Related: Other news.
BHIVA research awards deadline
1 June 2009. Related: BHIVA news.
Volume 10 Number 5/6 May/June 2009 PDF
1 June 2009. Related: PDFs.
Volume 10 Number 3/4 Mar/Apr 2009
30 April 2009. Related: Editorial.
16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2009, Montreal
30 April 2009. Related: Conference reports.
HIV infection in the brain: a long-term limitation of HAART?
26 April 2009. Related: Conference reports.
When to start HAART – a key research question with the least available data
26 April 2009. Related: Conference reports.
Major studies rule out any benefit of Interleukin-2 (IL-2): results from ESPRIT and SILCAAT
26 April 2009. Related: Conference reports.
Higher rates of non-AIDS cancers in HIV positive people
26 April 2009. Related: Conference reports, Cancer and HIV.
Effect of breast feeding vs formula feeding on maternal health
26 April 2009. Related: Conference reports, Pregnancy.
PEPI-Malawi
26 April 2009. Related: Conference reports, Pregnancy.
Premature delivery and mother-to-child HIV transmission: a risk/benefit analysis among women receiving HAART
20 April 2009. Related: Conference reports, Pregnancy.
Risk factors for adverse pregnancy outcomes in Botswana
20 April 2009. Related: Conference reports, Pregnancy.
Higher risk of transmission with delayed control of maternal viral load despite viral loads of <500 copies/mL at delivery
20 April 2009. Related: Conference reports, Pregnancy.
Lopinavir/r containing regimen superior to nevirapine containing regimen in women previously exposed to single dose nevirapine
20 April 2009. Related: Conference reports, Pregnancy.
Covering the nevirapine tail
20 April 2009. Related: Conference reports, Pregnancy.
Effect of single dose nevirapine on subsequent nevirapine-containing HAART: long term outcomes
20 April 2009. Related: Conference reports, Pregnancy.
High rates of HIV acquisition in pregnancy and post partum in Francistown, Botswana
20 April 2009. Related: Conference reports, Pregnancy.
Children on HAART do extremely well at South African clinic
20 April 2009. Related: Conference reports, Paediatric care.
New boosting alternatives to ritonavir: GS-99350 and SPI-452
20 April 2009. Related: Conference reports.
Interactions with raltegravir: with twice-daily atazanavir and standard dose lamotrigine
20 April 2009. Related: Conference reports.
Effect of tenofovir on abacavir phosphorylation
20 April 2009. Related: Conference reports, PK and drug interactions.
Nevirapine: fluconazole and TB treatment
20 April 2009. Related: Conference reports, TB coinfection.